0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-User, Therapeutic Areas - Global Forecast 2025-2030- Product Image
Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-User, Therapeutic Areas - Global Forecast 2025-2030- Product Image
Sale

Veterinary Antibiotics Market by Class (Aminoglycosides, Amphenicols, Cephalosporins), Animal Type (Companion Animals, Livestock), End-User, Therapeutic Areas - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 6021513
UP TO EUR$697USDGBP OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Antibiotics Market grew from USD 2.58 billion in 2023 to USD 2.81 billion in 2024. It is expected to continue growing at a CAGR of 9.01%, reaching USD 4.73 billion by 2030.

Veterinary antibiotics have emerged as a critical foundation in animal health, forming the backbone of treatments for a myriad of bacterial infections that threaten both companion animals and livestock. Over the past decade, advances in veterinary medicine have not only enhanced treatment protocols but also spurred vigorous debates on responsible antibiotic use, resistance management, and environmental sustainability. This report provides a deep dive into market fundamentals and the evolving scenario, underscoring both opportunities and challenges in a highly regulated sector.

The ever-increasing global demand for efficient animal health solutions has been propelled by factors such as rapid population growth within the livestock sector, rising pet ownership, intensified farming practices, and a heightened awareness of zoonotic threats to public health. Industry participants have been compelled to balance the urgent need to treat infections with the broader imperative to minimize antibiotic resistance. In response, regulatory bodies have introduced stringent oversight measures, while research institutes and companies are innovating to enhance drug efficacy and safety.

Additionally, the integration of novel diagnostic tools and emerging technologies into veterinary practices has redefined treatment standards, providing a new lens through which animal healthcare is approached. This introductory analysis sets the stage for a comprehensive examination of market dynamics, diverse segmentation factors, and actionable insights that cater to decision-makers and experts alike.

Transformative Shifts in the Veterinary Antibiotics Landscape

The landscape of veterinary antibiotics has experienced transformative shifts influenced by an amalgamation of technology, regulatory reforms, and changing consumer behaviors. Market players are now navigating a complex maze of evolving standards, with significant investments in research and development leading to more targeted formulations and improved safety profiles.

Digital transformation has enabled the rapid dissemination of clinical data and real-time monitoring of antibiotic use, promoting a more strategic approach to treatment protocols. This shift in technology has paved the way for more precise diagnostics and the tailoring of treatments to specific pathogens, thereby reducing the blanket use of broad-spectrum antibiotics. Regulatory authorities have responded with coordinated global frameworks aimed at curbing antimicrobial resistance, driving companies and clinics to revise protocols and adopt novel strategies that align with international best practices.

Equally important are the sustainability initiatives now embedded within corporate strategies. Ethical considerations and environmental stewardship are increasingly at the forefront, as industry leaders strive to reduce the ecological footprint of antibiotic production and usage. The renewed focus on integrated health management has led to cross-sector collaborations, where stakeholders in animal health, public health, and research converge to foster innovation. These holistic shifts are reshaping market dynamics, establishing a competitive environment that rewards both scientific breakthroughs and responsible stewardship.

Key Segmentation Insights in Veterinary Antibiotics

The market is intricately segmented into several key dimensions that provide a layered understanding of trends and consumer demands. One of the primary segmentation bases is by class, where antibiotics are categorized into diverse groups. The landscape under this segmentation includes well-known classes such as Aminoglycosides, Amphenicols, Cephalosporins, Fluoroquinolones, Macrolides, Other Quinolones, Penicillins, Polymixins, Sulfonamides, Tetracyclines, and Trimethoprim. Within these classes, the analysis dives deeper; for example, Aminoglycosides is comprehensively studied based on agents like Amikacin, Apramycin, Gentamicin, Kanamycin, and Neomycin. Similarly, Amphenicols are examined through compounds such as Azidamfenicol, Chloramphenicol, Florfenicol, Metiamycin, and Thiamphenicol, while Cephalosporins extend into sub-categories including Cefalexin, Cefalonium, Cefazolin, Cefovecin, Ceftiofur, and Ceftriaxone. The domain of Fluoroquinolones is scrutinized with a focus on Ciprofloxacin, Danofloxacin, Difloxacin, Enrofloxacin, Norfloxacin, and Orbifloxacin.

Additional segmentation dimensions include animal type, which distinguishes between Companion Animals - specifically cats and dogs - and Livestock, encompassing cattle, poultry, sheep and goats, as well as swine. Beyond the animal categorization, the market analysis further segments by end-user, identifying trends across animal production facilities, household pet owners, and veterinary clinics. Therapeutic areas further refine the segmentation, with studies concentrated on conditions such as dermatological, gastrointestinal, reproductive system, respiratory, soft tissue and wound, systemic, and urinary tract infections. This intricate framework allows for a robust analysis of market needs, pricing dynamics, and product innovations, supporting stakeholders in making informed decisions based on precise sub-sector data.

Based on Class, market is studied across Aminoglycosides, Amphenicols, Cephalosporins, Fluoroquinolones, Macrolides, Other Quinolones, Penicillins, Polymixins, Sulfonamides, Tetracyclines, and Trimethoprim. The Aminoglycosides is further studied across Amikacin, Apramycin, Gentamicin, Kanamycin, and Neomycin. The Amphenicols is further studied across Azidamfenicol, Chloramphenicol, Florfenicol, Metiamycin, and Thiamphenicol. The Cephalosporins is further studied across Cefalexin, Cefalonium, Cefazolin, Cefovecin, Ceftiofur, and Ceftriaxone. The Fluoroquinolones is further studied across Ciprofloxacin, Danofloxacin, Difloxacin, Enrofloxacin, Norfloxacin, and Orbifloxacin. The Macrolides is further studied across Azithromycin, Clarithromycin, Erythromycin, Gamithromycin, Spiramycin, Tilmicosin, Tulathromycin, and Tylosin. The Other Quinolones is further studied across Cinoxacin, Nalidixic Acid, Oxolinic Acid, Pipemidic Acid, and Rosoxacin. The Penicillins is further studied across Amoxicillin, Ampicillin, Cloxacillin, Oxacillin, Penicillin G, and Penicillin V. The Polymixins is further studied across Colistin/Polymyxin E and Polymyxin B. The Sulfonamides is further studied across Sulfadiazine, Sulfamerazine, Sulfamethizole, Sulfamethoxazole, and Sulfasalazine. The Tetracyclines is further studied across Chlortetracycline, Doxycycline, Oxytetracycline, and Tetracycline. The Trimethoprim is further studied across Trimethoprim Plus Sulfamethazine, Trimethoprim-Sulfadiazine, Trimethoprim-Sulfadimidine, Trimethoprim-Sulfadoxine, and Trimethoprim-Sulfamethoxazole (TMP-SMX).

Based on Animal Type, market is studied across Companion Animals and Livestock. The Companion Animals is further studied across Cats and Dogs. The Livestock is further studied across Cattle, Poultry, Sheep & Goats, and Swine.

Based on End-User, market is studied across Animal Production Facilities, Household Pet Owners, and Veterinary Clinics.

Based on Therapeutic Areas, market is studied across Dermatological Infections, Gastrointestinal Infections, Reproductive System Infections, Respiratory Infections, Soft Tissue & Wound Infections, Systemic Infections, and Urinary Tract Infections.

Key Regional Insights Across Global Markets

Regional dynamics play a pivotal role in shaping market trends and investment decisions. The Americas continue to lead considerable innovations driven by a well-established network of veterinary services coupled with high consumer awareness about antibiotic stewardship. Trends in the region are heavily influenced by robust regulatory environments that prompt investments in technology and diagnostics.

Across Europe, Middle East and Africa, organisms are witnessing an evolving scenario marked by tighter regulatory controls, increasing public and private partnerships, and heightened focus on sustainable practices. These regions emphasize harmonizing regulatory standards with market growth strategies while prioritizing research on antibiotic resistance.

In Asia-Pacific, rapid urbanization and booming animal husbandry practices are combined with increased household pet ownership, creating a dual channel of demand. The diverse demographic and economic trends in this region are fueling innovation cycles and fostering market competition on fronts previously untapped.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Veterinary Antibiotics Sector

The competitive landscape in veterinary antibiotics is defined by a constellation of companies committed to clinical excellence and product innovation. Industry leaders with a significant footprint include Ashish Life Science Private Limited and Bimeda Inc., both known for their targeted strategies in niche market segments. Firms such as Biogénesis Bagó S.A., C.H. Boehringer Sohn AG & Co. KG, and Ceva Santé Animale have bolstered their reputations through consistent product quality and adherence to rigorous safety protocols.

Moreover, companies like Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, and Elanco Animal Health Incorporated have risen as dominant players by integrating advanced technologies into production workflows. Intas Pharmaceuticals Ltd. and Krka, d. d., Novo mesto are further emphasizing research that not only meets clinical need but also addresses the global movement towards sustainability. Other prominent companies including Kyoritsuseiyaku Corporation, LABORATORIO AVI-MEX, LABORATORIOS CALIER, S.A., Merck KGaA, and Neogen Corporation have made notable contributions with innovative drug portfolios and strategic regional expansions. Additionally, market champions such as Ourofino Group, Sequent Scientific Ltd., Vetoquinol SA, Virbac SA, and Zoetis Inc. continue to shape market trends, proving their commitment to both innovation and ethics in an increasingly competitive arena.

The report delves into recent significant developments in the Veterinary Antibiotics Market, highlighting leading vendors and their innovative profiles. These include Ashish Life Science Private Limited, Bimeda Inc., Biogénesis Bagó S.A., C.H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Krka, d. d., Novo mesto, Kyoritsuseiyaku Corporation, LABORATORIO AVI-MEX, LABORATORIOS CALIER, S.A., Merck KGaA, Neogen Corporation, Ourofino Group, Sequent Scientific Ltd., Vetoquinol SA, Virbac SA, and Zoetis Inc..

Actionable Recommendations for Industry Leaders

Industry leaders can capitalize on emerging opportunities by adopting a multifaceted approach that combines rigorous R&D, strategic partnerships, and astute market forecasting. It is recommended that companies invest significantly in research to develop more targeted antibiotics that can effectively manage resistance while ensuring animal safety. Progressive leaders should also stress transparency in operations by aligning their strategies with evolving regulatory frameworks and global best practices.

To remain competitive, organizations should enhance supply chain efficiencies and integrate advanced diagnostic technologies that allow for rapid, accurate treatment decisions. Collaboration across various sectors - ranging from biotechnology research centers to veterinary clinics - can accelerate product innovations and facilitate market penetration in emerging regions. Furthermore, diversification strategies through geographic expansion and tailored product offerings can ensure a resilient response to fluctuating market dynamics.

The alignment of business models with ethical considerations and sustainability mandates is not just advisable but necessary, as consumer trust pivots on the responsible use of antibiotics. All these actions collectively offer a robust blueprint for firms aiming to not only adapt to market disruptions but also drive the next wave of growth.

In conclusion, the veterinary antibiotics market is marked by dynamic shifts and evolving segmentation landscapes which are deeply intertwined with regulatory progress and technological advancements. A thorough understanding of the class-based breakdown, animal type nuances, end-user requirements, and therapeutic priorities provides industry stakeholders with the strategic clarity needed to navigate this complex landscape. Moving forward, balancing innovation with responsible antibiotic use will be essential to ensure both market growth and public health success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing livestock population with increasing demand for dairy and meat products
5.1.1.2. Rising prevalence of zoonotic diseases and other infections in animals
5.1.1.3. Increasing companionship and humanization of pets across the globe
5.1.2. Restraints
5.1.2.1. Growing concerns about antibiotic resistance in veterinary disease antigens
5.1.3. Opportunities
5.1.3.1. Advances in drug delivery systems that enhance the efficacy and safety of veterinary antibiotics
5.1.3.2. Growing potential with the development of new antibiotics with novel mechanisms
5.1.4. Challenges
5.1.4.1. Issues related to the ban and restricted use of veterinary antibiotics in different regions
5.2. Market Segmentation Analysis
5.2.1. Class: Rising demand for amphenicols in various countries for treating respiratory diseases in cattle and fish
5.2.2. Animal Type: Usage of veterinary-antibiotics livestocks to ensure safe food supply chains and economic stability for farmers
5.2.3. End-User: Adoption of veterinary antibiotics in animal production facilities to prevent disease outbreaks and ensure optimal growth rates.
5.2.4. Therapeutic Areas: Utilization of veterinary antibiotics in respiratory infection to prevent outbreaks and maintain herd health,
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Veterinary Antibiotics Market, by Class
6.1. Introduction
6.2. Aminoglycosides
6.2.1. Amikacin
6.2.2. Apramycin
6.2.3. Gentamicin
6.2.4. Kanamycin
6.2.5. Neomycin
6.3. Amphenicols
6.3.1. Azidamfenicol
6.3.2. Chloramphenicol
6.3.3. Florfenicol
6.3.4. Metiamycin
6.3.5. Thiamphenicol
6.4. Cephalosporins
6.4.1. Cefalexin
6.4.2. Cefalonium
6.4.3. Cefazolin
6.4.4. Cefovecin
6.4.5. Ceftiofur
6.4.6. Ceftriaxone
6.5. Fluoroquinolones
6.5.1. Ciprofloxacin
6.5.2. Danofloxacin
6.5.3. Difloxacin
6.5.4. Enrofloxacin
6.5.5. Norfloxacin
6.5.6. Orbifloxacin
6.6. Macrolides
6.6.1. Azithromycin
6.6.2. Clarithromycin
6.6.3. Erythromycin
6.6.4. Gamithromycin
6.6.5. Spiramycin
6.6.6. Tilmicosin
6.6.7. Tulathromycin
6.6.8. Tylosin
6.7. Other Quinolones
6.7.1. Cinoxacin
6.7.2. Nalidixic Acid
6.7.3. Oxolinic Acid
6.7.4. Pipemidic Acid
6.7.5. Rosoxacin
6.8. Penicillins
6.8.1. Amoxicillin
6.8.2. Ampicillin
6.8.3. Cloxacillin
6.8.4. Oxacillin
6.8.5. Penicillin G
6.8.6. Penicillin V
6.9. Polymixins
6.9.1. Colistin/Polymyxin E
6.9.2. Polymyxin B
6.10. Sulfonamides
6.10.1. Sulfadiazine
6.10.2. Sulfamerazine
6.10.3. Sulfamethizole
6.10.4. Sulfamethoxazole
6.10.5. Sulfasalazine
6.11. Tetracyclines
6.11.1. Chlortetracycline
6.11.2. Doxycycline
6.11.3. Oxytetracycline
6.11.4. Tetracycline
6.12. Trimethoprim
6.12.1. Trimethoprim Plus Sulfamethazine
6.12.2. Trimethoprim-Sulfadiazine
6.12.3. Trimethoprim-Sulfadimidine
6.12.4. Trimethoprim-Sulfadoxine
6.12.5. Trimethoprim-Sulfamethoxazole (TMP-SMX)
7. Veterinary Antibiotics Market, by Animal Type
7.1. Introduction
7.2. Companion Animals
7.2.1. Cats
7.2.2. Dogs
7.3. Livestock
7.3.1. Cattle
7.3.2. Poultry
7.3.3. Sheep & Goats
7.3.4. Swine
8. Veterinary Antibiotics Market, by End-User
8.1. Introduction
8.2. Animal Production Facilities
8.3. Household Pet Owners
8.4. Veterinary Clinics
9. Veterinary Antibiotics Market, by Therapeutic Areas
9.1. Introduction
9.2. Dermatological Infections
9.3. Gastrointestinal Infections
9.4. Reproductive System Infections
9.5. Respiratory Infections
9.6. Soft Tissue & Wound Infections
9.7. Systemic Infections
9.8. Urinary Tract Infections
10. Americas Veterinary Antibiotics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Veterinary Antibiotics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Veterinary Antibiotics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Innovative Vetlen pouch enhances antibiotic delivery for veterinary care
13.3.2. Innovative antibacterial agents target antibiotic-resistant infections
13.3.3. FDA establishes veterinary innovation centers to advance animal health
13.3.4. Purdue and Akston Biosciences partner for innovative canine cancer treatment development
13.3.5. Dechra Pharmaceuticals to acquire invetx for enhanced veterinary biotherapeutics portfolio
13.3.6. FDA approves pradalex for targeted Use in cattle and swine respiratory treatment
13.3.7. Blacksmith Medicines and Zoetis collaborate to tackle antibiotic resistance in animal health
13.4. Strategy Analysis & Recommendation
13.4.1. Intas Pharmaceuticals Ltd.
13.4.2. Merck KGaA
13.4.3. Elanco Animal Health Incorporated
13.4.4. Zoetis Inc.
List of Figures
FIGURE 1. VETERINARY ANTIBIOTICS MARKET MULTI-CURRENCY
FIGURE 2. VETERINARY ANTIBIOTICS MARKET MULTI-LANGUAGE
FIGURE 3. VETERINARY ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 4. VETERINARY ANTIBIOTICS MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, 2018-2030 (USD THOUSAND)
FIGURE 6. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 7. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 8. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 10. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 12. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 14. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 16. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 18. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 20. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
FIGURE 24. VETERINARY ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. VETERINARY ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. VETERINARY ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, 2018-2030 (USD THOUSAND)
TABLE 4. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 5. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 6. VETERINARY ANTIBIOTICS MARKET DYNAMICS
TABLE 7. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 8. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 9. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMIKACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 10. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY APRAMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 11. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 12. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY KANAMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 13. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NEOMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 14. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 15. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 16. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AZIDAMFENICOL, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 17. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CHLORAMPHENICOL, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 18. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLORFENICOL, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 19. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY METIAMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 20. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THIAMPHENICOL, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 21. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 22. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 23. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFALEXIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 24. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFALONIUM, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 25. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFAZOLIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 26. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFOVECIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 27. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFTIOFUR, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 28. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEFTRIAXONE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 29. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 30. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 31. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CIPROFLOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 32. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DANOFLOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 33. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DIFLOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 34. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ENROFLOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 35. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NORFLOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 36. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ORBIFLOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 37. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 38. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 39. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AZITHROMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 40. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLARITHROMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 41. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ERYTHROMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 42. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GAMITHROMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 43. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SPIRAMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 44. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TILMICOSIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 45. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TULATHROMYCIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 46. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 47. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 48. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 49. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CINOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 50. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY NALIDIXIC ACID, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 51. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXOLINIC ACID, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 52. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PIPEMIDIC ACID, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 53. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ROSOXACIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 54. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 55. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 56. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 57. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 58. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLOXACILLIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 59. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXACILLIN, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 60. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLIN G, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 61. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLIN V, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 62. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 63. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 64. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COLISTIN/POLYMYXIN E, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 65. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMYXIN B, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 66. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 67. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 68. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFADIAZINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 69. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMERAZINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 70. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMETHIZOLE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 71. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFAMETHOXAZOLE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 72. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFASALAZINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 73. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 74. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 75. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CHLORTETRACYCLINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 76. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DOXYCYCLINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 77. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY OXYTETRACYCLINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 78. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 79. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 80. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 81. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM PLUS SULFAMETHAZINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 82. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFADIAZINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 83. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFADIMIDINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 84. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFADOXINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 85. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM-SULFAMETHOXAZOLE (TMP-SMX), BY REGION, 2018-2030 (USD THOUSAND)
TABLE 86. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 87. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 88. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 89. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 90. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 91. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 92. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 93. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 94. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 95. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 96. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 97. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 98. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 99. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL PRODUCTION FACILITIES, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 100. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY HOUSEHOLD PET OWNERS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 101. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 102. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 103. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY DERMATOLOGICAL INFECTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 104. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 105. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY REPRODUCTIVE SYSTEM INFECTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 106. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 107. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SOFT TISSUE & WOUND INFECTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 108. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY SYSTEMIC INFECTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 109. GLOBAL VETERINARY ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD THOUSAND)
TABLE 110. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 111. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 112. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 113. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 114. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 115. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 116. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 117. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 118. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 119. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 120. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 121. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 122. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 123. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 124. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 125. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 126. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 127. AMERICAS VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 128. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 129. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 130. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 131. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 132. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 133. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 134. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 135. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 136. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 137. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 138. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 139. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 140. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 141. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 142. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 143. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 144. ARGENTINA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 145. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 146. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 147. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 148. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 149. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 150. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 151. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 152. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 153. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 154. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 155. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 156. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 157. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 158. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 159. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 160. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 161. BRAZIL VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 162. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 163. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 164. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 165. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 166. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 167. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 168. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 169. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 170. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 171. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 172. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 173. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 174. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 175. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 176. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 177. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 178. CANADA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 179. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 180. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 181. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 182. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 183. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 184. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 185. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 186. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 187. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 188. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 189. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 190. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 191. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 192. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 193. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 194. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 195. MEXICO VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 196. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 197. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 198. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 199. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 200. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 201. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 202. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 203. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 204. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 205. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 206. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 207. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 208. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 209. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 210. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 211. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 212. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 213. UNITED STATES VETERINARY ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
TABLE 214. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 215. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 216. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 217. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 218. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 219. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 220. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 221. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 222. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 223. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 224. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 225. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 226. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 227. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 228. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 229. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 230. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 231. ASIA-PACIFIC VETERINARY ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
TABLE 232. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 233. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 234. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 235. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 236. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 237. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 238. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 239. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 240. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 241. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 242. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 243. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 244. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 245. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 246. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 247. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 248. AUSTRALIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 249. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 250. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 251. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 252. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 253. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 254. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 255. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 256. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 257. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 258. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 259. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 260. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 261. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 262. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 263. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 264. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 265. CHINA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 266. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 267. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 268. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 269. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 270. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 271. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 272. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 273. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 274. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 275. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 276. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 277. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 278. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 279. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 280. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 281. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 282. INDIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 283. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 284. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 285. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 286. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 287. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 288. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 289. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 290. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 291. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 292. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 293. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 294. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 295. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 296. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 297. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 298. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 299. INDONESIA VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 300. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 301. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 302. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 303. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 304. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 305. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 306. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 307. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 308. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 309. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 310. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 311. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)
TABLE 312. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD THOUSAND)
TABLE 313. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD THOUSAND)
TABLE 314. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD THOUSAND)
TABLE 315. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
TABLE 316. JAPAN VETERINARY ANTIBIOTICS MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD THOUSAND)
TABLE 317. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CLASS, 2018-2030 (USD THOUSAND)
TABLE 318. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2030 (USD THOUSAND)
TABLE 319. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY AMPHENICOLS, 2018-2030 (USD THOUSAND)
TABLE 320. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORINS, 2018-2030 (USD THOUSAND)
TABLE 321. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 322. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2030 (USD THOUSAND)
TABLE 323. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY OTHER QUINOLONES, 2018-2030 (USD THOUSAND)
TABLE 324. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY PENICILLINS, 2018-2030 (USD THOUSAND)
TABLE 325. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY POLYMIXINS, 2018-2030 (USD THOUSAND)
TABLE 326. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2030 (USD THOUSAND)
TABLE 327. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TETRACYCLINES, 2018-2030 (USD THOUSAND)
TABLE 328. MALAYSIA VETERINARY ANTIBIOTICS MARKET SIZE, BY TRIMETHOPRIM, 2018-2030 (USD THOUSAND)

Companies Mentioned

  • Ashish Life Science Private Limited
  • Bimeda Inc.
  • Biogénesis Bagó S.A.
  • C.H. Boehringer Sohn AG & Co. KG
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Intas Pharmaceuticals Ltd.
  • Krka, d. d., Novo mesto
  • Kyoritsuseiyaku Corporation
  • LABORATORIO AVI-MEX
  • LABORATORIOS CALIER, S.A.
  • Merck KGaA
  • Neogen Corporation
  • Ourofino Group
  • Sequent Scientific Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

Methodology

Methodology DOWNLOAD NOW

Table Information

Report AttributeDetails
No. of Pages189
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.73 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030 - Product Image

Veterinary Antibiotics Market Size, Share & Trends Analysis Report by Animal Type (Pigs, Cattle, Sheep & Goats, Poultry), Drug Class (Tetracyclines, Penicillins), Dosage Form, Region, and Segment Forecasts, 2025-2030

  • Report
  • 258 Pages
  • Global
From
EUR$5,950USDGBP
Animal Antibiotics and Antimicrobials - Global Strategic Business Report - Product Image

Animal Antibiotics and Antimicrobials - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
EUR$5,600USDGBP
Veterinary Antibiotics Market Report 2025 - Product Image

Veterinary Antibiotics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Animal Antibiotics and Antimicrobials Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Animal Antibiotics and Antimicrobials Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
EUR$4,500USDGBP
Ruminant Feed Antibiotics Market Report 2025 - Product Image

Ruminant Feed Antibiotics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP

About the Veterinary Antibiotics Market

The Veterinary Antibiotics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the production and distribution of antibiotics for use in animals. Veterinary antibiotics are used to treat a variety of bacterial infections in animals, including respiratory, gastrointestinal, and urinary tract infections. They are also used to prevent and control the spread of infectious diseases in animals. Veterinary antibiotics are available in a variety of forms, including tablets, capsules, liquids, and injectables. Veterinary antibiotics are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. Veterinary antibiotics are typically prescribed by veterinarians and dispensed by pharmacies. In some cases, they may be available over-the-counter. Some companies in the Veterinary Antibiotics market include Bayer, Merck, Zoetis, Elanco, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more